gyki 12743 has been researched along with Decerebrate Posturing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horváth, E; Jaszlits, L; Rabloczky, G | 1 |
| Bódi, I; Horváth, E; Jaszlits, L; Rabloczky, G | 1 |
2 other study(ies) available for gyki 12743 and Decerebrate Posturing
| Article | Year |
|---|---|
GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
Topics: Adrenergic alpha-Antagonists; Animals; Azepines; Blood Pressure; Clonidine; Decerebrate State; Dioxanes; Electric Stimulation; Heart Rate; Idazoxan; Phentolamine; Phenylephrine; Pyridazines; Rats; Rats, Inbred Strains; Yohimbine | 1991 |
Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
Topics: Adrenergic alpha-Antagonists; Animals; Decerebrate State; Dioxanes; Dioxins; Dogs; In Vitro Techniques; Male; Mice; Muscle, Smooth; Muscle, Smooth, Vascular; Pyridazines; Rabbits; Rats; Synapses | 1990 |